 Patients with chronic hepatitis B infection CHI awaiting assisted reproduction usually require antiviral therapy due to vertical transmission risk and laboratory safety. However, no consensus is reached regarding the medication. This study aimed to explore the efficacy and safety of tenofovir TDF and telbivudine LdT in this population. 